BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28286738)

  • 41. MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer.
    Chen MB; Wei MX; Han JY; Wu XY; Li C; Wang J; Shen W; Lu PH
    Cell Signal; 2014 Jan; 26(1):102-9. PubMed ID: 23899558
    [TBL] [Abstract][Full Text] [Related]  

  • 42. p53 Deletion or Hotspot Mutations Enhance mTORC1 Activity by Altering Lysosomal Dynamics of TSC2 and Rheb.
    Agarwal S; Bell CM; Taylor SM; Moran RG
    Mol Cancer Res; 2016 Jan; 14(1):66-77. PubMed ID: 26385560
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.
    Shin J; Yang J; Lee JC; Baek KH
    Cell Signal; 2013 Dec; 25(12):2540-7. PubMed ID: 23993963
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A small molecule inhibitor of Rheb selectively targets mTORC1 signaling.
    Mahoney SJ; Narayan S; Molz L; Berstler LA; Kang SA; Vlasuk GP; Saiah E
    Nat Commun; 2018 Feb; 9(1):548. PubMed ID: 29416044
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Selective inhibition of growth of tuberous sclerosis complex 2 null cells by atorvastatin is associated with impaired Rheb and Rho GTPase function and reduced mTOR/S6 kinase activity.
    Finlay GA; Malhowski AJ; Liu Y; Fanburg BL; Kwiatkowski DJ; Toksoz D
    Cancer Res; 2007 Oct; 67(20):9878-86. PubMed ID: 17942919
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulation of Small Intestinal Epithelial Homeostasis by Tsc2-mTORC1 Signaling.
    Setiawan J; Kotani T; Konno T; Saito Y; Murata Y; Noda T; Matozaki T
    Kobe J Med Sci; 2019 Apr; 64(6):E200-E209. PubMed ID: 31327863
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Platelet-derived growth factor-induced p42/44 mitogen-activated protein kinase activation and cellular growth is mediated by reactive oxygen species in the absence of TSC2/tuberin.
    Finlay GA; Thannickal VJ; Fanburg BL; Kwiatkowski DJ
    Cancer Res; 2005 Dec; 65(23):10881-90. PubMed ID: 16322235
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acute myotube protein synthesis regulation by IL-6-related cytokines.
    Gao S; Durstine JL; Koh HJ; Carver WE; Frizzell N; Carson JA
    Am J Physiol Cell Physiol; 2017 Nov; 313(5):C487-C500. PubMed ID: 28768641
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Insulin-like growth factor-I-coupled mitogenic signaling in primary cultured human skeletal muscle cells and in C2C12 myoblasts. A central role of protein kinase Cdelta.
    Czifra G; Tóth IB; Marincsák R; Juhász I; Kovács I; Acs P; Kovács L; Blumberg PM; Bíró T
    Cell Signal; 2006 Sep; 18(9):1461-72. PubMed ID: 16403461
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of gene expression array in TSC2-deficient AML cells reveals IRF7 as a pivotal factor in the Rheb/mTOR pathway.
    Makovski V; Jacob-Hirsch J; Gefen-Dor C; Shai B; Ehrlich M; Rechavi G; Kloog Y
    Cell Death Dis; 2014 Dec; 5(12):e1557. PubMed ID: 25476905
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ankyrin repeat and suppressor of cytokine signaling (SOCS) box-containing protein (ASB) 15 alters differentiation of mouse C2C12 myoblasts and phosphorylation of mitogen-activated protein kinase and Akt.
    McDaneld TG; Spurlock DM
    J Anim Sci; 2008 Nov; 86(11):2897-902. PubMed ID: 18641171
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Distinct roles of Rheb and Raptor in activating mTOR complex 1 for the self-renewal of hematopoietic stem cells.
    Peng H; Kasada A; Ueno M; Hoshii T; Tadokoro Y; Nomura N; Ito C; Takase Y; Vu HT; Kobayashi M; Xiao B; Worley PF; Hirao A
    Biochem Biophys Res Commun; 2018 Jan; 495(1):1129-1135. PubMed ID: 29175333
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ReishiMax inhibits mTORC1/2 by activating AMPK and inhibiting IGFR/PI3K/Rheb in tumor cells.
    Sohretoglu D; Zhang C; Luo J; Huang S
    Signal Transduct Target Ther; 2019; 4():21. PubMed ID: 31637001
    [No Abstract]   [Full Text] [Related]  

  • 54. Overexpression of the Tuberous sclerosis complex 2 (TSC2) gene inhibits goat myoblasts proliferation and differentiation in understanding the underlying mechanism of muscle development.
    Lyu M; Shalitana A; Luo J; He H; Sun S; Wang P
    Gene; 2020 Oct; 757():144943. PubMed ID: 32652105
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rheb phosphorylation is involved in p38-regulated/activated protein kinase-mediated tumor suppression in liver cancer.
    Zheng M; Zang S; Xie L; Fang X; Zhang YU; Ma X; Liu J; Lin D; Huang A
    Oncol Lett; 2015 Sep; 10(3):1655-1661. PubMed ID: 26622727
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HSP70 interacts with Rheb, inhibiting mTORC1 signaling.
    Ryu HH; Ha SH
    Biochem Biophys Res Commun; 2020 Dec; 533(4):1198-1203. PubMed ID: 33059920
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acute effects of a ketone monoester, whey protein, or their coingestion on mTOR trafficking and protein-protein colocalization in human skeletal muscle.
    Hannaian SJ; Lov J; Cheng-Boivin Z; Abou Sawan S; Hodson N; Gentil BJ; Morais JA; Churchward-Venne TA
    Am J Physiol Cell Physiol; 2024 Jun; 326(6):C1769-C1775. PubMed ID: 38682238
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Consequences of interrupted Rheb-to-AMPK feedback signaling in tuberous sclerosis complex and cancer.
    Lacher MD; Pincheira RJ; Castro AF
    Small GTPases; 2011 Jul; 2(4):211-216. PubMed ID: 22145093
    [TBL] [Abstract][Full Text] [Related]  

  • 59. TSC2 S1365A mutation potently regulates CD8+ T cell function and differentiation and improves adoptive cellular cancer therapy.
    Patel CH; Dong Y; Koleini N; Wang X; Dunkerly-Eyring BL; Wen J; Ranek MJ; Bartle LM; Henderson DB; Sagert J; Kass DA; Powell JD
    JCI Insight; 2023 Nov; 8(21):. PubMed ID: 37788104
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CGEF-1 regulates mTORC1 signaling during adult longevity and stress response in
    Li Y; Finkbeiner S; Ganner A; Gerber J; Klein M; Grafe M; Kandzia J; Thien A; Thedieck K; Breves G; Jank T; Baumeister R; Walz G; Neumann-Haefelin E
    Oncotarget; 2018 Feb; 9(11):9581-9595. PubMed ID: 29515755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.